final program.qxd - Parallels Plesk Panel
final program.qxd - Parallels Plesk Panel
final program.qxd - Parallels Plesk Panel
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
SS 2.1<br />
The Lessons we have Learned over the Last Decade<br />
No abstract available<br />
SS 2.2<br />
Differentiating between Different Options<br />
No abstract available<br />
SS 2.3<br />
The Future of Therapy<br />
No abstract available<br />
SS 3.1<br />
Brain and HIV<br />
Jacques Gasnault, Kremlin-Bicêtre - France<br />
A greater number of patients over 50 years of age are now living with HIV in industrialized<br />
countries. This epidemiologic trend will continue to increase as a result of both prolonged<br />
survival due to effective antiretroviral treatment and the growing proportion of delayed<br />
diagnoses of older individuals with occult HIV disease. Despite a better virological<br />
response to combination antiretroviral therapy (cART), older patients are at a higher risk<br />
of HIV disease progression than youngers, for at least two reasons: first, they tend to be<br />
diagnosed at a more advanced stage; second, they have a delayed immune response to<br />
cART. There is emerging evidence that older HIV-infected individuals may be at greater<br />
risk for cognitive disorders. Some studies have identified a higher frequency of<br />
neurocognitive dysfunction in older than in younger HIV-infected persons. This impairment<br />
may vary in severity from a dementing illness (HIV-associated dementia) to a mild clinical<br />
change (minor cognitive motor disorders). Because of the overlap in cognitive functions<br />
that are affected by aging as well as by HIV-1 infection, one might expect that aging may<br />
potentiate the effects of HIV-1 on cognition in older individuals. In HIV-infected individuals<br />
as in general population, older age has been found to be associated with higher risk of<br />
complications as cardiovascular disease or diabetes, which can lead to a cognitive<br />
decline. The observation that HIV, advanced age, and concomitant neurodegenerative<br />
disorders as Alzheimer disease may interact in additive or synergistic ways raises many<br />
questions regarding best practice among this population.<br />
SS 3.2<br />
Long-Term Cardiovascular Troubles of HIV Patients<br />
No abstract available<br />
SS 3.3<br />
Cancer and HIV<br />
No abstract available<br />
“ Focusing FIRST on PEOPLE “ 280 w w w . i s h e i d . c o m
Change language